Glycobond uses recombinant technology to produce carbohydrate-binding peptides with defined specificities for use primarily in diagnosis and monitoring of liver diseases and cancer. The company’s first product is a CE-marked assay for aid in diagnosis of primary liver cancer, HepaCheC®.
Company Details
- Founded
- -
- Address
- Linköping, 583 30, Se
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.glycobond.com/
- Keywords
- Linköping.
- HQ
- Linköping
Glycobond Questions
Glycobond's website is https://www.glycobond.com/
Glycobond's LinkedIn profile is https://se.linkedin.com/company/glycobond
Glycobond's industry is
Biotechnology Research
Glycobond's top competitors are
Amun Ai Ab,
Nyzu,
Dohi,
Objekt360,
Spira Energy Ab,
Linkura,
Wayfin Solutions Pvt Ltd,
Techlane Ab,
Schemagi - Schemaspecialisterna,
Forento.io.
Glycobond's categories are Biotechnology Research
Glycobond's founding year is 2011
